« Previous
Next »
Gastroenterology
Volume 136, Issue 3
, Pages
760-763
, March 2009
Nitazoxanide: Beyond Parasites Toward a Novel Agent for Hepatitis C
Conflicts of interest Michael W. Fried receives grant support from several companies that make competing products including Roche, Vertex, Human Genome Sciences, Wyeth, and Tibotec. He has no interest in or support from Romark, the sponsor of the study this editorial refers to.
Dr Darling discloses no conflicts.
PII: S0016-5085(09)00050-X
doi: 10.1053/j.gastro.2009.01.020
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 136, Issue 3
, Pages
760-763
, March 2009

